Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban Treatment Discontinuation Rates in Routine Clinical Practice in Italy in Patients With Non-valvular Atrial Fibrillation

NCT04174859 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04174859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04174859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban Treatment Discontinuation Rates in Routine Clinical Practice in Italy in Patients With Non-valvular Atrial Fibrillation
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
December 10, 2019
Completion date
December 12, 2022
Enrollment
812 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-valvular atrial fibrillation